P.e.e.r. Pals, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 200 W 2nd St, 228-a, Freeport, TX 77541 Phone: 713-724-3603 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed neurologists have low awareness of Novartis/Mitsubishi Tanabe's FTY-720 (Gilenia) among the surveyed oral emerging therapies for the treatment of multiple sclerosis (MS).
It is often easy to tell when a person has suffered a severe traumatic brain injury, but it is much more difficult to detect and determine the amount of brain damage a person has suffered when the injury is mild.
Researchers from the University of California, San Francisco (UCSF) and Makerere University in Uganda have used hair and blood samples from three-month old infants born to HIV-positive mothers to measure the uninfected babies' exposure—both in the womb and from breast-feeding—to antiretroviral medications their mothers were taking. The results, they said, are surprising.
"More than 80 percent of health departments in the United States that treat tuberculosis [TB] resistant to standard treatment have trouble obtaining the drugs they need to cure the disease, according to a national survey released on Thursday," Reuters reports.
› Verified 9 days ago